American CryoStem Corporation
OTC: CRYO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John S. Arnone
- Employees
- 4
- Headquarters
- Eatontown, United States
- IPO year
- 2010
- Market cap
- $4.4K
- Website
- https://www.americancryostem.com
Loading CRYO…
Loading profile data…Frequently asked questions about CRYO
What does American CryoStem Corporation (CRYO) do?
American CryoStem Corporation (ACSC) specializes in the development, commercialization, and licensing of technologies derived from adipose (fat) tissue, primarily for applications within regenerative and personalized medicine. Among its key offerings is the CELLECT system, designed to streamline tissue sample collection, transportation, and stor...
Where does CRYO trade?
American CryoStem Corporation (CRYO) trades on the Other OTC.
What sector is CRYO in?
American CryoStem Corporation (CRYO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of American CryoStem Corporation?
John S. Arnone is the chief executive officer of American CryoStem Corporation (CRYO).
Where is American CryoStem Corporation headquartered?
American CryoStem Corporation is headquartered in United States.
Does CRYO pay a dividend?
American CryoStem Corporation (CRYO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CRYO go public?
American CryoStem Corporation (CRYO) completed its initial public offering in 2010.